会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • USE OF ENGINEERED RENAL TISSUES IN ASSAYS
    • 在测定中使用工程化的肾脏组织
    • WO2018064323A1
    • 2018-04-05
    • PCT/US2017/053997
    • 2017-09-28
    • ORGANOVO, INC.
    • KING, Shelby MarieNGUYEN, Deborah Lynn GreenePRESNELL, Sharon C.
    • C12N5/07C12N5/09G01N33/50
    • Disclosed are methods of assessing the ability of a candidate therapeutic agent to reverse, reduce or prevent renal injury by a potential toxic agent using a three-dimensional, engineered, bioprinted, biological renal tubule model. Also disclosed are methods of assessing the effect of an agent on renal function, the method comprising contacting the agent with a three-dimensional, engineered, bioprinted, biological renal tubule model. Also disclosed are models of renal disorder. In one embodiment, disclosed are models of renal fibrosis, comprising a three- dimensional, engineered, bioprinted, biological renal tubule model. Also disclosed are methods of making the model of renal disorder. In one embodiment disclosed are methods of making the model of renal fibrosis comprising contacting a three-dimensional, engineered, bioprinted, biological renal tubule model with an agent that is capable of inducing interstitial fibrotic tissue formation.
    • 公开了使用三维工程化生物打印的生物肾小管模型来评估候选治疗剂逆转,减少或预防潜在毒性剂引起的肾损伤的能力的方法。 还公开了评估药剂对肾功能的作用的方法,所述方法包括使所述药剂与三维工程化生物打印的生物肾小管模型接触。 还公开了肾病的模型。 在一个实施方案中,公开了包含三维工程化生物打印的生物肾小管模型的肾纤维化模型。 还公开了制造肾病模型的方法。 在一个实施方案中公开了制备肾纤维化模型的方法,其包括使三维工程化生物打印的生物肾小管模型与能够诱导间质纤维化组织形成的药剂接触。